World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston

Bayer at World CDx 2026

Oct 5–8, 2026 Boston, MA ~900 attendees Website

Bayer takes part in 2 sessions at World CDx 2026 in Boston. Its sessions center on taking drugs and their companion diagnostics through trials and approval together across countries. Most distinctive is regulatory strategy for approving diagnostics alongside gene therapies, and how marketing requirements shape it.

OrganizationWorld CDx 2026 Attendance
Bayer
Leverkusen, Germany
Large pharma
German life science group whose pharmaceuticals division markets medicines in oncology, cardiology, women's health and other areas.
Talk
Wed Oct 7
12:50pm
Regulatory Strategies for Dx-Rx Approvals for Gene Therapies & Impact of Marketing Requirements
Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access
Panel
Wed Oct 7
3:10pm
Innovating Global Rx-Dx Trial Pathways Through Strategic & Compliant Co-Development Partnerships to Deliver Harmonized Precision Medicine Solutions
with Astellas, Pfizer, Agilent
Clinical & companion diagnostic developmentDrug–diagnostic commercialization & access

Explore the full World CDx 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full World CDx 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bayer

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World CDx or its organizers. Submit a correction